Johnson & Johnson Completes Acquisition of Intra-Cellular Therapies
US-based Johnson & Johnson (NYSE: JNJ) announced the completion of its acquisition of fellow American...
Company
Yuewei Medtech Secures RMB100 Million in Series A++ Funding for Cardiac Device Development
Beijing Yuewei Medical Technology Co., Ltd, a medical device company specializing in coronary heart disease,...
Boehringer Ingelheim Reports 6.1% Sales Growth in 2024, Bolstered by Key Pharmaceuticals
Germany-based Boehringer Ingelheim released its 2024 financial report, recording group net sales of EUR 26.8...
GE Healthcare Partners with Probo Medical to Distribute Ultrasound Devices
US medical device and life sciences giant GE Healthcare Technologies Inc. (NASDAQ: GEHC) has entered...
Henlius Biotech’s HLX04-O Shows Positive Results in wAMD Phase III Trial
China-based Shanghai Henlius Biotech Inc. (HKG: 2696) has announced positive results from the Phase III...
Mabwell Bioscience’s 7MW3711 ADC Receives Clinical Trial Approval in China
China-based Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) announced that it has received clinical trial...
Sinovac Partners with CPMA to Advance Vaccine Preventable Disease Initiatives
China-based Sinovac Biotech Ltd (NASDAQ: SVA) has entered into a strategic memorandum of understanding (MoU)...
Novartis’ Vanrafia Gets FDA Accelerated Approval for IgAN
Switzerland-based Novartis (NYSE: NVS) announced that it has received accelerated approval from the US Food...
Sanofi and Cathay Capital Launch RMB 2 Billion Pharma Innovation Fund in China
The Sanofi Cathy Capital Pharmaceutical Innovation Fund, a joint venture between French pharmaceutical giant Sanofi...
Sihuan Pharma’s Polycaprolactone Microsphere Filler Gains NMPA Approval
China’s Sihuan Pharmaceutical Holdings Group Ltd (HKG: 0460) announced that it has received Category III...
Shionogi Partners with Link Medical for Cefiderocol Development in Australia and New Zealand
Japan-based Shionogi Co., Ltd. has entered into an exclusive licensing agreement with Link Medical Products...
WuXi XDC Partners with MABSOFT to Advance Innovative ADC Development
China-based WuXi XDC (HKG: 2268), a joint venture between WuXi Biologics (HKG: 2269) and WuXi...
Guojian Qingke Biomedical Gains NMPA Approval for 3D MSCs in Stroke Trials
China-based Guojian Qingke Biomedical Technology (Beijing) Co., Ltd. announced that it has received tacit clinical...
Gan & Lee Pharmaceuticals Secures Pakistan Approval for Insulin Glargine Cartridge
Gan & Lee Pharmaceuticals (SHA: 603087) has announced the receipt of marketing approval for its...
Biogen’s BIIB080 Receives FDA Fast Track Designation for Alzheimer’s
US-based Biogen Inc. (NASDAQ: BIIB) announced that it has received Fast Track designation (FTD) from...
Pfizer and Flagship Pioneering Collaborate on AI-Driven Drug Development
US pharmaceutical giant Pfizer Inc. (NYSE: PFE) has entered into a collaboration agreement with Flagship...
Nurix Therapeutics Expands Sanofi Partnership with Undisclosed TPD Program
US-based targeted protein degradation (TPD) specialist Nurix Therapeutics, Inc. (NASDAQ: NRIX) announced an expanded partnership...
Jiangxi Rimag Lists CT Chest Lesion Data on Shanghai Data Exchange
China-based medical imaging expert Jiangxi Rimag Group Co., Ltd (HKG: 2522) has announced the successful...
Novartis’ Fabhalta Approved in China for C3 Glomerulopathy
Novartis’ (NYSE: NVS) Fabhalta (iptacopan) has received approval from China’s National Medical Products Administration (NMPA)...
Shionogi Submits Rolling NDA for Ensitrelvir in US for COVID-19 Prophylaxis
Shionogi announced on April 1, 2025, the initiation of a rolling New Drug Application (NDA)...